FBTDX Mutual Fund (Franklin Biotechnology Discovery Fund Class C) is managed by Franklin Templeton Investments (US) with $46.6M in net assets. FBTDX expense ratio is 1.77%, holding 98 positions across sectors including Health Care, Unknown, Financials. Inception date: 2014-03-04.

FBTDX performance shows a YTD return of 19.79%. The 1-year return is 89.51% and the 5-year return is 12.31%. FBTDX dividend yield stands at 1.49%, paid annually.

FBTDX top holdings include Gilead Sciences Inc (6.2%), Amgen Inc. (4.8%), Nvaesrtex Pharmaceuticals Inc (4.7%), Jazz Pharmaceuticals Plc. (4.6%), Regeneron Pharmaceuticals, Inc. (4.4%). View all FBTDX holdings, sector breakdown, or dividend history.

FBTDX can be compared against other funds using the overlap calculator or side-by-side comparison tool. FBTDX alternatives are available via the screener, along with tax-loss harvesting opportunities.